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ABSTRACT 
Introduction: A multicenter parallel three-arm randomized clinical trial was carried out in three 
UK university hospitals to investigate the effect of supplemental vibratory force on space closure 
and treatment outcome with fixed appliances. Methods: Eighty-one subjects <20 years of age 
with mandibular incisor irregularity undergoing extraction-based fixed-appliance treatment were 
randomly allocated to supplementary (20-minutes/day) use of an intra-oral vibrational device 
(AcceleDent®) (Accel-group) (n=29), an identical non-functional (sham) device (Accel-sham) 
(n=25), or fixed-appliances only (Fixed-only) (n=27). Overall space closure in the mandibular arch 
was measured from dental study casts taken at start of space closure (T1), at the following 
appointment (T2), and at completion (T3). Final records were taken at completion of treatment 
(T4). Data were analyzed blindly on a per-protocol basis with descriptive statistics, one-way 
analysis of variance, and linear regression modeling with 95% Confidence Intervals (CI). Results: 
Sixty-one subjects remained in the trial at start of space closure with all three groups comparable 
for baseline characteristics. The overall median rate of initial mandibular arch space closure 
(primary outcome) was 0.89 mm/month with no difference for either the Accel-group (difference=-
0.09 mm/month; 95% CI=-0.39 to 0.22 mm/month; P=0.57) or Sham-group (difference=-0.02 
mm/month; 95% CI=-0.32 to 0.29 mm/month; P=0.91) compared to the Fixed-only group. 
Similarly, no significant differences were identified between groups for secondary outcomes, 
including overall treatment duration (median=18.6 months; P>0.05), number of visits (median=12; 
P>0.05) and % improvement in Peer Assessment Index (median=90.0%; P>0.05). Conclusions: 
Supplemental vibratory force during orthodontic treatment with fixed appliances does not affect 
space closure, treatment duration, total number of visits or final occlusal outcome. Registration: 
NCT02314975. Protocol: The protocol was not published before trial commencement. Funding: 
AcceleDent® units were donated by the OrthoAccel Technologies Inc, Texas USA; no contribution 
into the conduct or writing of this study was made by the manufacturer. 
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INTRODUCTION 
Despite numerous innovations and advances in orthodontic appliance design and application, the 
average duration of comprehensive treatment with fixed appliances has remained relatively stable 
at just under twenty months 1. Accelerated orthodontic treatment is desirable; not only to limit the 
social and dental inconvenience of wearing fixed appliances, but also to help reduce the 
established risks of iatrogenic damage 2. Over the years, numerous innovations and adjuncts have 
been described that purport to speed up tooth movement and reduce overall treatment time. There 
is currently no robust evidence for faster tooth movement and reduced treatment time in 
association with any particular appliance design 3,4, bracket prescription 5, archwire composition 6 
or treatment adjunct 7. The sole exception are surgical interventions, such as corticotomies or 
piezocision that do seem to accelerate tooth movement, albeit on a relatively short-term basis 8. 
However, most of these surgical techniques are invasive and may not be readily acceptable to the 
majority of subjects 9. Therefore, continued efforts are directed towards the search for a safe, 
predictable and acceptable method to reduce orthodontic treatment time, without compromising 
clinical results. 
The use of supplemental vibrational force has been advocated as a method of speeding 
up orthodontic tooth movement. This involves the application of low-level vibration directly to the 
dentition as it is subjected to orthodontic force. The basic principle underlying orthodontic tooth 
movement is the ability of alveolar bone to respond with remodeling following the application of 
external force 10. Using this principle, vibrational force has been shown to aid in the maintenance 
of bone mass in post-menopausal women 11 or subjects with reduced mobility and prolonged bed-
rest 12-14. At the same time, data from animal models indicates an increased rate of tooth 
movement, osteoclastic activity and bone remodeling within the periodontium 15,16. These data 
have been used to inform the development of commercial vibrational appliances for clinical use, 
one of which is AcceleDent® (OrthoAccel Technologies, Houston, Texas USA). This is a hands-
free portable device consisting of an activator unit and removable thermoplastic occlusal wafer, 
which the patient bites onto. The activator unit vibrates and delivers a force of 0.2 N at a frequency 
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of 30 Hz to the dentition. The manufacturer suggests that it is used for 20 minutes per day in order 
to increase the speed of tooth movement and thereby reduce treatment time. 
Clinical benefits from the use of supplemental vibration have been reported from case 
reports and non-randomized retrospective cohort studies 17-20. These investigations have shown 
increases in the rate of orthodontic tooth movement and a reduction in treatment time, but their 
non-randomized and retrospective design exposes them to potential bias and exaggerated 
treatment effects 21. There is data from randomized studies demonstrating statistically significant 
effects of supplemental vibration when delivered using either AcceleDent or a vibrating toothbrush 
during orthodontic treatment 22,23. These data are at both the clinical and biochemical level; but 
again, the methodological design of both these studies predisposes them to a high risk of bias 24. 
These encouraging results have not been confirmed by other randomized clinical trials 
investigating rates of tooth movement, which have found no significant benefit from supplemental 
vibrational force 25-27. However, these trials have only reported on the initial alignment phase with 
fixed appliances and no robust evidence exists to date in relation to rates of space closure or 
overall treatment time when using fixed appliances with supplemental vibration. 
 
Specific objectives and hypothesis 
The aim of this study was to investigate the effect of AcceleDent appliance usage on the outcome 
of fixed appliance orthodontic treatment. The primary outcome measure for this component of the 
trial was initial rate of mandibular arch space closure, whilst secondary outcomes included overall 
rate of mandibular space closure, treatment duration, number of visits, appliance breakages and 
PAR reduction during treatment. The null hypothesis is that the use of supplemental vibrational 
force does not improve the rate of mandibular arch space closure, overall treatment duration or 
outcome in subjects undergoing comprehensive extraction treatment using fixed appliances. 
 
MATERIALS AND METHODS 
Trial design and any changes after trial commencement  
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Data for this investigation were gathered from the follow-up of a three-arm parallel randomized 
controlled trial comparing the effect of supplemental vibrational force on orthodontic tooth 
alignment 27 and are reported according to the CONSORT statement 28. Ethical approval was 
obtained from the UK National Research Ethics Service (South East London REC 3: 11/LO/0056) 
and written-informed consent received from all parents, guardians and subjects. This trial was 
registered at the European Clinical Trials Database (EudraCT, 2014-004211-37) on September 
29, 2014 and ClinicalTrials.gov (NCT02314975) on November 25, 2014. No changes to 
methodology occurred after trial commencement. There were no changes to the trial after 
commencement. 
 
Participants, eligibility criteria and settings 
Participants were recruited from subjects referred to the orthodontic departments at King’s College 
London Dental Institute (Guy’s Hospital); the Royal Alexander Children’s Hospital, Brighton, 
Sussex; and William Harvey Hospital, Ashford, Kent, United Kingdom. The former is based in a 
dental school and the latter two are based in regional hospitals. All offer comprehensive 
orthodontic treatment for children and adults. Eligibility criteria have been previously described 27 
and included: (1) <20 years-old at start of treatment; (2) medically fit and well; (3) in the permanent 
dentition; (4) presence of mandibular incisor irregularity; and (5) bilateral mandibular first premolar 
extraction as part of the treatment plan. 
 
Interventions 
Participants were randomly assigned to one of three groups: (1) Pre-adjusted edgewise fixed-
appliance treatment with daily-use of an AcceleDent® (OrthoAccel® Technologies, Texas, USA) 
vibrational device (Accel-group); (2) Pre-adjusted edgewise fixed-appliance treatment with daily-
use of a non-functional (sham) AcceleDent device (Accel-sham) provided by the manufacturer; 
and (3) Pre-adjusted edgewise fixed-appliance treatment alone (Fixed-only). Subjects allocated 
to adjunctive devices were given direct verbal and written instruction on operation and usage, 
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instructed to use it for 20 minutes/day at a time of their choosing and informed that a timer was 
part of the device, which allowed the investigator to monitor compliance 27. 
Bonding method and fixed appliances were standardized (pre-coated 3M Victory-series 
brackets; MBT prescription; bonding of lower second permanent molars) with a pre-determined 
sequence of 0.014-inch, 0.018-inch, 0.017 x 0.025-inch nickel titanium (Ni-Ti) and 0.019 x 0.025-
inch stainless steel (SS) archwires. Data collection relating to the alignment phase of treatment 
took place at start of treatment (baseline), placement of 0.018-inch Ni-Ti (initial alignment) and 
0.019 x 0.025-inch SS (completion of alignment) and have been previously reported 27,29,30. All 
appointments were made as part of the routine orthodontic treatment provided within the 
participating departments and scheduled at approximately 6-week intervals. No bite-planes, 
auxiliary-arches, or headgears were used during the period of space closure, but inter-maxillary 
elastics were permitted as prescribed. All subjects were treated by senior orthodontists (ATD, NJ, 
CS, JG, MTC) or postgraduate specialist trainees (NRW, MA) under their direct supervision. 
For this component of the trial, space closure was initiated at the first visit following 
placement of a 19 x 25-inch SS working archwire (completion of alignment) and undertaken using 
9 mm Ni-Ti coil springs attached from the first molar to hooks placed on the archwire between 
lateral incisor and canine, and stretched to no more than twice their length, as per manufacturer 
instructions. Data was collected at the start of mandibular space closure (T1); at the first visit 
following initiation of space closure (T2), at the end of space closure in the mandibular arch (T3) 
and at completion of treatment on removal of the fixed appliances (T4). Coil springs were checked 
during routine adjustments between T1-T3 and retied. If there was any sign of damage they were 
replaced with a spring of the same dimensions. Specifically, dated mandibular (T1-T3) and both 
maxillary and mandibular (T4) alginate impressions were taken for the generation of dental study 
casts. 
For mandibular arch space closure: space was measured using Mitutoyo IP67 150-mm 
digital-calipers (Mitutoyo, UK) by placing the caliper tip from (the most concave) contact point-to-
contact point between mandibular second premolar and canine bilaterally and calculating a mean 
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value for each subject. A sample of 20 subjects was randomly chosen and re-measured by the 
same assessor (MA) after two weeks for repeatability. Repeatability and agreement of the 
measurements were assessed with the Concordance Correlation Coefficient 31 and the Bland-
Altman method 32. Monthly rates of mandibular arch space closure were calculated by dividing 
mean space closure value by the exact number of space closure days divided by 30 (days). 
All subjects in the trial had first premolar extractions in the mandibular arch. In the maxillary 
arch, all subjects had a single tooth extracted in each quadrant but these extraction patterns varied 
and were classified as those with premolar extractions, canine or incisor extractions or a 
combination. 
For Peer Assessment Rating (PAR) index 33: dental casts taken at baseline and T4 were 
scored by a single calibrated examiner. 
 
Outcomes (primary and secondary) 
The primary outcome measure for this component of the trial was initial rate of mandibular arch 
space closure (T1-T2, calculated as mm/month). Secondary outcomes included overall rate of 
mandibular arch space closure (in mm/month), overall treatment duration (in months), overall 
number of visits, number of appliance breakages and both absolute and relative (%) PAR 
reduction during treatment. 
 
Sample size calculation 
The primary outcome for the present component of the trial was initial rate of mandibular arch 
space closure. No formal sample size calculation was performed for this component because it is 
a follow-up examination of a previous randomized clinical trial 27. However, a previous randomized 
trial investigating three methods of orthodontic space closure calculated that 11 subjects per group 
(33 subjects in total) would yield a power of 90% to detect a clinically significant difference in space 
closure at quadrant level (0.75 ± 0.50 mm/month) with α=5% 34, which indicated that the primary 
outcome for this component of the trial was adequately powered. 
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Randomization 
The randomization sequence was computer-generated using GraphPad online software 
(http://www.graphpad.com/quickcalcs/index.cfm) with participant allocation undertaken centrally 
at King’s College London, independently from the clinical operators following recruitment 
(allocation concealment) 35 35. No restricted randomization or stratification was utilized. 
 
Blinding 
By the nature of the trial intervention, subjects and treating clinicians were aware of treatment 
group allocation. Dental casts were coded so that all measurements were undertaken blind. All 
dental cast linear measurements were carried out blind by a single investigator (MA). PAR scoring 
was also conducted blind for all dental casts by a single calibrated examiner (YK). 
 
Statistical analysis 
Statistical analysis was conducted on a per-protocol basis and blinded with a coded dataset, 
where the code was broken after final provision of the analysis results. Data normality was 
checked via visual inspection of distributional diagrams and formal testing with the Shapiro-Wilk 
test. As all outcomes were non-normally distributed (P<0.05), descriptive statistics consisted of 
medians and inter-quartile ranges (IQRs). Initial crude differences among randomized groups 
were calculated with Kruskal–Wallis one-way analysis of variance. 
 Subsequent linear regression models were fitted with independent variables for either the 
randomization group (crude analysis) or additional confounders, including the possible influence 
of study center 36. Choice of the latter was based on both on clinical judgment and on whether 
bivariable model fit improved with a criterion-based method using a model with just the dependent 
variable 37. Assumptions of linear regression for all fitted models were checked including graphical 
and statistical tests for homoscedasticity of residuals, multicollinearity of predictors, and model 
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misspecification. Results are reported as unstandardized coefficients and 95% confidence 
intervals (CIs) with α set at 5%. 
Post hoc explorative analyses were conducted to investigate any systematic differences 
across centers in terms of average time interval between appointments. Additionally, interactions 
of randomized interventions’ effects with baseline severity of irregularity, baseline extraction 
spaces and baseline PAR scores were investigated (with cut-offs of 7 mm, 7 mm and 30 points, 
respectively). The main (per-protocol) analysis that was conducted excluded (i) subjects that 
reported not using their Accel or Accel-sham appliance (n=9), (ii) cases of early fixed appliance 
removal at subject request (n=2), cases with more than 3 missed appointments (n=5), those with 
more than 5 episodes of fixed appliance breakage (n=2), one case with an impacted maxillary 
canine and one case undergoing orthognathic surgery. A separate sensitivity analysis was 
performed with the intention-to-treat sample by including all excluded subjects with available data 
and compared to the main analysis for robustness. 
 
RESULTS 
A CONSORT diagram demonstrating subject flow through the trial is shown in Figure 1. Eighty-
one subjects were recruited into the trial between July 2011-May 2014, with 29 allocated to the 
Accel-group, 25 to Accel-sham and 27 to Fixed-only. The total randomized sample consisted of 
40 males and 41 females with a mean age of 14.1 (SD, 1.7) years. The mean age of subjects 
allocated to the Accel-group was 13.9 (SD 1.6) years, to Accel-sham 14.1 (SD 1.9) years and to 
Fixed-only was 14.4 (SD 1.8) years. 
 Table 1 shows baseline demographics of subjects investigated in the present component 
of the trial. A total of 61 subjects remained in the trial at T1, which included 22 in the Accel-group, 
19 in the Accel-sham, and 20 in the Fixed-only group. These three groups were comparable for 
all patient characteristics at baseline (Table 1). 
 
Outcomes and estimation 
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The mean time period from T1-T2 was 68 ±28 days and from T1-T3 was 172 ±79 days. For the 
primary outcome of initial rate of mandibular arch space closure the median across all randomized 
subjects was 0.89 mm/month (IQR=0.56 to 1.33 mm/month) with no significant differences among 
groups (P=0.61; Figure 2; Table 2). In addition, no significant differences among groups were 
identified for any secondary outcomes, including overall rate of mandibular arch space closure 
(median [IQR]=0.74 [0.56 to 1.00] mm/month), overall treatment duration (median [IQR]=18.57 
[16.3 to 23.9] months), number of visits (median [IQR]= 12 [10 to 16] visits), number of breakages 
(median [IQR]=2 [1 to 3] breakages), final PAR score (median [IQR]=3 [2 to 4] points) and absolute 
(median [IQR]=28 [21 to 35] points) or % improvement in PAR score (median [IQR]=90.0% [84.6% 
to 93.8%]) (P>0.05 in all instances). 
 These findings were also confirmed by regression analyses with either crude (including 
only experimental groups and study center-effects) or adjusted (experimental groups, study 
center-effects, and confounders) models (Table 3). No differences could be found in initial space 
closure rate between either the Accel-group or Accel-sham and the Fixed-only group (P=0.57 and 
P=0.91, respectively). The only factors that significantly influenced space closure rate were patient 
gender, extraction category in the maxillary arch and the amount of initial space to be closed (with 
male patients, extraction of upper anterior teeth, and increased baseline space positively 
associated with closure rate; P<0.05 in all three cases; Table 3). 
No differences in the average time interval between appointments could be found among 
the three study centres (Supplementary Table 1). 
 No significant interactions of treatment effects could be found with baseline severity of 
irregularity, extraction spaces to be closed or PAR score (Supplementary Table 2), indicating that 
the effect of an Acceledent appliance did not differ between ‘easy’ and ‘difficult’ cases. 
 
Repeated measurements, sensitivity analysis, and harms 
The agreement of repeated measurements was found to be excellent by the Bland-Altman limits 
of agreement (mean difference <0.05 mm) and the CCC (CCC>0.99; Supplementary Table 3). 
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Finally, the intention-to-treat results of the sensitivity analysis (Supplementary Table 4-8) 
contributed to the robustness of the analysis, as they were in complete agreement with the per-
protocol analysis (Tables 1-3). 
 The only harms assessed in this trial were appliance breakages, where there were no 
significant differences among randomized groups (Tables 2-3). 
 
DISCUSSION 
Main findings in the context of existing evidence 
The results of this study show no clinical or statistical difference between groups in relation to the 
initial rate of mandibular arch space closure. There was likewise, no significant difference among 
groups for overall space closure rate in the mandible, total treatment time, number of visits, 
breakages or final static occlusal outcome (measured with PAR), indicating that the use of 
supplemental vibrational force had no beneficial effect on orthodontic treatment with fixed 
appliances. There was actually an association between use of AcceleDent and increased overall 
treatment time but this was only close to significance (P=0.07; Table 2). It is difficult to explain why 
this association might have existed, given the equivalence between randomized groups 
demonstrated in all the other outcomes investigated, but it does support previous research 
showing that the use of vibrational force does not influence rate of tooth movement during 
alignment with fixed appliances 25-27. However, it is at odds with other studies that have shown 
increased rates of maxillary canine retraction and molar distalization in the presence of vibration 
18,22,23 and indeed, reductions in time to achieve perceived levelling 17 and completion of treatment 
in highly selected cases 20. 
In the present investigation, both rates of space closure in all three groups were 
comparable to other studies using Ni-Ti coil springs. Previous research investigating space closure 
using sliding mechanics have reported rates per month ranging from 0.64 mm to 2.04 mm 34,38-43. 
The median in this study across all three groups was 0.89 mm per month, with no significant 
difference among groups. Additionally, there was a significant relationship between the amount of 
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extraction space at the start of the study and both space closure rates: the larger the total 
extraction space the higher the rate of space closure. This may be due to a greater activation of 
the Ni-Ti springs over larger extraction spaces or a statistical artifact. The initial rates of space 
closure were higher than the overall rates reported for all three groups. This may be a reflection 
of the time-intervals between appointments; the subjects were seen approximately every six to 
eight weeks as per standard clinical practice (averaged time-interval between appointments: 
median=50.7 days; P>0.05 across centers; Supplemental Table 1). Therefore, extraction spaces 
might well have been fully closed in certain cases some time before the T3 records were actually 
collected, resulting in a reduction of the extrapolated measured overall rate of space closure. 
While all participants had lower first premolars extracted, extraction patterns in the 
maxillary arch varied according to malocclusion and the specific treatment plan. While this did not 
directly impact upon treatment duration, number of visits or the overall rate of space closure, it did 
affect the initial rate in the lower arch. However, no post hoc pairwise comparisons were 
performed, as this was not the main scope of the trial, patient distribution was fairly uneven and 
to avoid unnecessary Type I error inflation. Similarly, the prescription and use of inter-arch elastics 
was not formally measured as part of the trial and this could potentially have influenced space 
closure rates. However, the distribution of class II and III malocclusions was comparable between 
intervention groups (Table 1) and unlikely to have been a significant cofactor during space closure. 
Whilst some anecdotal evidence exists on the matter, to the authors’ knowledge no study 
has reported on the effect of supplemental vibratory force on overall duration or outcome of 
comprehensive fixed-appliance treatment 19,20,44. The results of this trial cannot support a reduction 
in treatment time, fewer visits, or a greater PAR reduction in subjects who used the AcceleDent 
device. The treatment duration reported in this study is comparable to that reported in previous 
prospective studies for extraction-based treatment with fixed appliances 1 and to the average 
treatment time reported in a recent systematic review 29. 
The mean PAR reduction in this trial for all three groups was above 22 points (or 70% of 
the baseline PAR) indicating a great improvement in relation to occlusal outcomes, irrespective of 
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the use of either the active or sham Acceledent device 33. This is in part a reflection of the inclusion 
criteria, particularly in relation to the severity of crowding or malalignment. Unsurprisingly, the 
greater the initial PAR score (and therefore, the more severe the case), the greater the relative 
improvement in the PAR score with treatment. The reduction in PAR reported in this study showed 
the cases were treated to a high standard in all three groups, implying no operator bias or 
indication that the study subjects’ treatment was rushed in an attempt to produce positive findings 
for the trial intervention. 
 
Limitations 
Like many long-term clinical trials that follow subjects to the end of treatment, this study was 
subject to significant drop-out, making it potentially susceptible to attrition bias, particularly in 
relation to long-term non-compliance with the AcceleDent appliance. However, drop-out was 
similar across the three groups (24% overall; 24%, 24% and 26% per group; Figure 1), which in 
combination with the comparability of the finally-analyzed sample for age, initial irregularity and 
presenting malocclusion, implies that any effect on trial outcomes might be negligible. In addition, 
even with the relatively high levels of drop out, the numbers in each group were still greater than 
those required from the sample size calculation for primary outcome 34, making the analyses and 
findings valid and applicable. However, the analysis for some secondary outcomes might be 
underpowered and caution is warranted in their interpretation. 
It is also not possible to state that the applied space-closing mechanics were absolutely 
consistent between extraction sites throughout the sample because the forces were not quantified 
and there is evidence that force magnitude can influence rate of tooth movement 45,46. Some 
individual variation will exist amongst clinicians and whilst the activation scheme was standardized 
a priori so that the springs were not stretched more than twice their length, variance can exist 
between forces delivered by different springs activated to the same distance 47-50. The age of 
eligibility for the study was <20 years, which means that some variation in development and 
relative maturity may have existed between groups, which can also affect rate of tooth movement 
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45. This could also partially explain the gender effects reported, in that for the same chronological 
age, female subjects could be more mature and less biologically responsive to the same 
orthodontic force than their male counterparts. 
The subjects in this investigation were all undergoing routine orthodontic treatment in three 
clinical settings. Appointments were made at approximately six to eight week intervals but it is 
possible that some data collection took place beyond the specific time-point of achieving the 
desired tooth movement, specifically the completion of space closure and completion of overall 
treatment. Unless subjects are seen almost weekly this is a potential confounder, but difficult to 
avoid when conducting clinical studies in a real-world setting. The manufacturer of this appliance 
does not mention that treatment modalities need to be changed or that patients need to be seen 
more regularly when using this device. We have tested the use of supplemental vibration with 
fixed appliances on adolescent patients using conventional treatment mechanics. For the claims 
that have been made in relation to the use of vibrational force to be of relevance to practicing 
clinicians they need to be testable in such an environment and clinically relevant. 
While the operators and analyst in this study were blinded to initial allocation, the subjects 
were asked to use the AcceleDent appliance immediately before each clinical appointment, which 
made it impossible to blind the operator to group allocation. Asking subjects to bring their device 
and use it prior to each appointment was done as a means of allowing the operator to verify 
continued appliance usage and compliance. However, we acknowledge that operator-blinding 
would have been a desirable methodological addition. Although true blinding of participants has 
been claimed in a previous randomized investigation of AcceleDent, it is difficult to believe that 
most subjects appropriately informed about the nature of such a trial during the consent process, 
would not realize fairly soon that they had been allocated a non-functional (non-vibrating) device 
23. All the AcceleDent units (both active and sham) in the present study contained electronic timers 
that could be read off an LED screen in the housing unit; however, these were the first timers to 
be incorporated in this device by the manufacturer and unfortunately, they did not work. The 
collection of formal compliance data was therefore not possible and the effect of inadequate 
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compliance on the results of this trial cannot be completely ruled out. The use of self-monitoring 
and reporting was considered during the planning of this trial, but this can result in over-estimation 
of compliance 51.  Advocates of vibrational force have been quick to criticize the methodology 
associated with prospective RCTs investigating this treatment intervention 52. No clinical trial is 
perfect, but these criticisms should be considered in the knowledge that the fundamental 
methodology associated with retrospective studies that have found differences is highly likely to 
be associated with bias 17,18,20. It is well established in medical research that retrospective study 
designs produce over-estimation of treatment effects and this includes clinical orthodontics 21. The 
accurate measurement of compliance is clearly an important issue and in the present study, 
despite repeated monitoring during the trial and the exclusion of non-compliers from the per-
protocol analysis, definitive data is lacking. However, the only available compliance data for these 
devices relates to either patient logbooks or evidence of the device being switched on, not 
switched on and necessarily in the mouth. We acknowledge this, but it is important to emphasize 
that compliance data is relevant for all studies, irrespective of whether they find positive or 
negative results. Two of the most commonly cited investigations endorsing the use of vibrational 
force to accelerate tooth movement (methodological flaws aside) report no formal compliance data 
17,23. 
 
Generalizability 
The study was carried out in three hospital orthodontic departments that offer comprehensive 
treatment for adolescents. The treatment was carried out either by experienced clinicians or by 
postgraduates under the direct supervision of experienced clinicians. The range, type and severity 
of malocclusions treated in this study in adolescent subjects using a common fixed-appliance 
system typical of most orthodontic caseloads. Also, the potential issues of compliance 
documented again are problems encountered in everyday clinical practice. We therefore feel that 
the results are applicable to orthodontic clinical practice for adolescent subjects treated with 
extractions in the majority of clinical settings. 
 16 
 
CONCLUSIONS 
This multicenter randomized controlled trial has investigated the influence of supplemental 
vibrational force on orthodontic tooth movement. In this component of the trial we report no 
benefits of vibration in terms of mandibular space closure rate, treatment duration and final 
treatment outcome. Within the limitations of this study and based upon cumulative prospective 
evidence we conclude that whilst the use of supplemental vibrational force with fixed appliances 
is not associated with increased appliance breakage it does not provide any advantages. 
Practitioners should consider this when recommending supplemental vibrational force to their 
subjects on the basis of reducing treatment time or any other added benefits. From the apparent 
results of this study, patients who purchase these vibration devices have the burden of costs 
without the advertised benefits. 
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Figure Legends 
Figure 1 CONSORT diagram showing the flow of subjects through the trial. B=Baseline; T1=Start of 
space closure; T2=First visit following T1; T3=End of space closure; T4=Completion of treatment. (*) n=1 
not analyzed for PAR score because the final model was not available. (+) It should be noted that in the 
Accel and Accel-sham groups 1 subject was lost from each group because they discontinued using the 
device; and in the fixed-only group, 1 subject was lost through early removal of the fixed appliance, all were 
lost prior to the completion of incisor alignment 27. In total, 6 subjects were lost from Brighton, 8 subjects 
were lost from Guys and 6 subjects were lost from Canterbury. 
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Figure 2 Cumulative graph showing predicted marginal treatment effects for primary and secondary 
outcomes of the present trial. Results are plotted as unstandardized regression coefficients with 95% CIs 
(blue) based on the adjusted models from Table 3. The graph has been augmented with contours of effect 
magnitude (grey shades) based on the SD in the reference group (Fixed-only) for each outcome. 
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Table 1. Baseline characteristics of trial subjects 
 
Characteristic Overall 
Accel-
group 
Sham-
group 
Fixed-only 
group 
Patient number - n 61 22 19 20 
Center BRIGHTON - n (%) 27 (44%) 8 (36%) 11 (58%) 8 (40%) 
Center GUYS - n (%) 10 (16%) 4 (18%) 1 (5%) 5 (25%) 
Center 3 - CANTERBURY (%) 24 (39%) 10 (45%) 7 (37%) 7 (35%) 
Male - n (%) 30 (49%) 11 (50%) 8 (42%) 11 (55%) 
Age - mean (SD) 13.9 (1.5) 13.6 (1.4) 13.9 (1.5) 14.3 (1.7) 
Baseline irregularity - mean (SD) 7.8 (3.2) 7.5 (3.2) 7.9 (3.3) 8.0 (3.3) 
Baseline PAR* - mean (SD) 33.0 (11.0) 34.0 (11.7) 30.9 (9.6) 33.9 (11.9) 
Class I - n (%) 22 (36%) 8 (36%) 7 (37%) 7 (35%) 
Class II - n (%) 22 (36%) 9 (41%) 6 (32%) 7 (35%) 
Class III - n (%) 17 (28%) 5 (23%) 6 (32%) 6 (30%) 
Premolar extractions - n (%)** 53 (87%) 21 (95%) 17 (89%) 15 (75%) 
Canine/incisor extractions - n (%)** 2 (3%) 0 (0%) 0 (0%) 2 (10%) 
Mixed extractions - n (%)** 6 (10%) 1 (5%) 2 (11%) 3 (15%) 
Extraction spaces - mean (SD) 8.0 (2.3) 8.3 (2.4) 8.2 (2.2) 7.4 (2.4) 
 
SD, standard deviation; PAR, peer assessment rating. 
*n=59 not 61 subjects (21, 19, and 19 subjects in groups Accel, Sham, and Fixed-only, respectively) 
** All subjects had mandibular arch first premolar extractions; these extraction categories relate to teeth that 
were extracted in the maxillary arch. 
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Table 2. Descriptive statistics and crude differences across groups. Data are given as median and interquartile range (IQR) and not as mean and 
standard deviation, as they are not normally distributed 
 
 Accel-group Sham-group Fixed-only group  
 n median IQR n median IQR n median IQR P* 
Initial rate of space closure 
T1-T2 (mm/month) 
22 0.82 0.48, 1.33 19 0.89 0.56, 1.13 20 0.95 0.65, 1.47 0.61 
Monthly space closure rate 
T1-T3 (mm/month) 
22 0.82 0.62, 1.06 19 0.68 0.57, 0.80 19 0.76 0.52, 1.01 0.42 
Treatment duration (months) 22 20.45 17.63, 25.23 19 16.73 15.33, 22.07 20 17.64 14.87, 23.89 0.07 
No of visits 22 14.5 11.0, 17.0 19 11.0 10.1, 14.0 20 11.0 9.5, 16.0 0.13 
No of breakages 22 2.0 1.0, 3.0 19 2.0 1.0, 3.0 20 2.0 1.0, 2.0 0.95 
PAR at T6 21 3.0 2.0, 6.0 19 3.0 2.0, 4.0 19 3.0 2.0, 4.0 0.60 
PAR Improvement 21 28.0 21.0, 38.0 19 27.0 20.0, 35.0 19 29.0 24.0, 31.0 0.91 
PAR Improvement % 21 88.9 80.9, 94.4 19 90.0 87.5, 92.0 19 91.2 85.0, 93.5 0.74 
 
PAR, peer assessment rating 
* from Kruskal-Wallis test 
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Table 3. Results of the crude and adjusted regression models for primary and secondary outcomes 
 
   Crude model: only group 
Adjusted modeling: group and 
confounding factors 
   b 95% CI P b 95% CI P 
Initial rate of space 
closure (T1-T2) 
Group 
(Ref=Fixed-only) 
Accel -0.10 -0.44,0.25 0.57 -0.07 -0.39,0.25 0.67 
  Sham -0.03 -0.39,0.32 0.85 -0.02 -0.34,0.31 0.92 
 Gender   NT     0.29 0.02,0.56 0.04 
 Malocclusion   NT     0.12 -0.05,0.28 0.15 
 Extraction   NT     0.24 0.02,0.47 0.03 
 Spaces T3   NT     0.08 0.03,0.14 0.005 
             
Overall rate of 
space closure (T1-
T3) 
Group 
(Ref=Fixed-only) 
Accel 0.11 -0.19,0.40 0.47 0.11 -0.17,0.39 0.43 
  Sham -0.11 -0.41,0.190 0.45 -0.12 -0.41,0.16 0.39 
 Gender   NT     0.18 -0.05,0.41 0.12 
 Malocclusion   NT     0.15 0.01,0.29 0.04 
 Extraction   NT     0.16 -0.03,0.35 0.11 
 Spaces T3   NT     0.05 0.00,0.10 0.03 
             
Treatment duration 
Group 
(Ref=Fixed-only) 
Accel 3.00 -0.39,6.40 0.08 2.19 -0.70,5.07 0.13 
  Sham -0.27 -3.79,3.26 0.88 0.85 -2.21,3.90 0.58 
 Gender  NT     -0.84 -3.24,1.57 0.49 
 PAR T1  NT     0.11 -0.01,0.22 0.07 
 Center (Ref=Brighton) Guys NT   3.21 2.06,9.14 0.002 
  Ashford NT   -4.31 2.84,8.27 <0.001 
         
             
Number of visits 
Group 
(Ref=Fixed-only) 
Accel 1.45 -0.69,3.59 0.18 1.01 -0.89,2.90 0.29 
  Sham -0.97 -3.20,1.25 0.39 -0.11 -2.10,1.88 0.91 
 Gender   NT     0.10 -0.92,1.13 0.84 
 Irregularity T1  NT   -0.13 -0.40,0.14 0.33 
 PAR T1   NT     0.05 -0.03,0.12 0.20 
 Center (Ref=Brighton) Guys NT   4.24 1.81,6.67 0.001 
  Ashford NT   2.81 0.97,4.64 0.003 
             
Number of 
breakages 
Group 
(Ref=Fixed-only) 
Accel 0.16 -1.10,1.42 0.80 0.10 -1.12,1.32 0.87 
  Sham -0.09 -1.40,1.21 0.89 -0.31 -1.60,0.97 0.63 
 Malocclusion   NT     0.63 -0.03,1.29 0.06 
 PAR T1   NT     -0.01 -0.06,0.04 0.68 
 Center (Ref=Brighton) Guys NT   -0.85 -2.36,0.66 0.26 
  Ashford NT   1.04 -0.15,2.23 0.09 
             
Change in PAR 
Group 
(Ref=Fixed-only) 
Accel -0.51 -7.43,6.42 0.88 -0.35 -1.60,0.90 0.57 
  Sham -2.37 -9.46,4.72 0.51 0.69 -0.62,2.01 0.30 
 PAR T1   NT     0.98 0.93,1.03 <0.001 
 Center (Ref=Brighton) Guys NT   0.86 -0.67,2.39 0.26 
  Ashford NT   -1.37 -2.54,-0.19 0.02 
             
% change in PAR 
Group 
(Ref=Fixed-only) 
Accel -2.22 -6.52,2.08 0.31 -1.54 -5.10,2.03 0.39 
  Sham 1.19 -3.22,5.59 0.59 2.78 -0.98,6.54 0.14 
 PAR T1   NT     0.31 0.17,0.45 <0.001 
 Center (Ref=Brighton) Guys NT   3.21 -1.15,7.57 0.15 
  Ashford NT   -4.31 -7.67,-0.96 0.01 
 27 
 
b, unstandardized coefficient; CI, confidence interval; NT, not tested; Ref, reference; PAR, peer assessment rating. 
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SUPPLEMENTARY DATA 
 
Supplementary Table 1. Explorative assessment of mean time intervals between appointments. 
 
 Accel-group Sham-group Fixed-only group  
 n median IQR n median IQR n median IQR P* 
Time interval in 
days 
22 50.7 45.7, 55.4 19 52.3 46.0, 57.4 20 48.3 44.7, 55.1 0.297 
 
IQR, interquartile range 
* from Kruskal-Wallis test 
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Supplementary Table 2. Explorative assessment for interaction effects on primary and secondary outcomes 
of severe irregularity at baseline, severe spaces at T1, and severe PAR at baseline. Significant P values 
indicate that the effect of randomized intervention on listed outcome differs between patients with severe and 
non-severe conditions. 
 
 P value for interaction 
 Severe irregularity 
(>7mm) 
Severe spacing 
(>7mm) 
Severe PAR (>30 
points) 
Initial rate of space closure (T1-T2) 0.708 0.756 0.399 
Treatment duration (months) 0.235 0.347 0.785 
% change in PAR 0.958 0.239 0.056 
 
PAR, peer assessment rating. 
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Supplementary Table 3. Results of reliability and agreement of repeated measurements 
 
 Mean 
95% Limits of 
agreement 
P (correlation: difference-mean) 
Limits of agreement -0.027 -1.044, 0.991 0.622 
 CCC 95% CI P 
CCC 0.999 0.999, 1.000 <0.001 
 
CCC, Concordance correlation coefficient; CI, Confidence Interval. 
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Supplementary Table 4. Demographics of the trial subjects (Intention-to-Treat analysis)* 
 
Characteristic Overall Accel Sham Fixed-only 
Patient number - n 64 24 19 21 
Center (Brighton) - n (%) 27 (42%) 8 (33%) 11 (58%) 8 (38%) 
Center (Guy’s) - n (%) 11 (17%) 4 (17%) 1 (5%) 6 (29%) 
Center 3 – (Canterbury) (%) 26 (41%) 12 (50%) 7 (37%) 7 (33%) 
Male - n (%) 31 (48%) 11 (46%) 8 (42%) 12 (57%) 
Age - mean (SD) 14.0 (1.8) 13.8 (1.8) 13.9 (1.5) 14.5 (2.0) 
Baseline irregularity - mean (SD) 7.9 (3.3) 7.8 (3.6) 7.9 (3.3) 8.0 (3.2) 
Baseline PAR - mean (SD) 32.8 (10.9) 33.5 (11.3) 30.9 (9.6) 33.9 (11.9) 
Class I - n (%) 24 (38%) 9 (38%) 7 (37%) 8 (38%) 
Class II - n (%) 22 (34%) 9 (38%) 6 (32%) 7 (33%) 
Class III - n (%) 18 (28%) 6 (25%) 6 (32%) 6 (29%) 
Premolar extractions - n (%) 56 (88%) 23 (96%) 17 (89%) 16 (76%) 
Canine/incisor extractions - n (%) 2 (3%) 0 (0%) 0 (0%) 2 (10%) 
Mixed extractions - n (%) 6 (9%) 1 (4%) 2 (11%) 3 (14%) 
 
SD, standard deviation; PAR, peer assessment rating 
*n=61, not 64 patients (23, 19 and 19 subjects in Accel, Sham, and Fixed-only groups, respectively) 
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Supplementary Table 5. Descriptive statistics and crude differences across groups. Data are given as medians and IQR and not as means and SDs, as they are 
not normally distributed (Intention-to-Treat analysis) 
 
 Accel-group Sham-group Fixed-only group  
 n median IQR n median IQR n median IQR P* 
Initial rate of space closure rate (T1-T2) 
(mm/month) 
24 0.74 0.45,1.24 19 0.89 0.56,1.13 21 0.94 0.62,1.44 0.592 
           
Overall rate of space closure (T1-T3) (mm/month) 23 0.80 0.62,1.06 19 0.68 0.57,0.80 19 0.76 0.52,1.01 0.442 
Treatment duration (months) 24 20.45 18.05,25.92 19 16.73 15.33,22.07 20 17.64 14.87,23.89 0.046 
No of visits 24 14.5 11.5,16.5 19 11.0 10.0,14.0 20 11.0 9.5,16.0 0.108 
No of breakages 24 2.0 1.0,4.0 19 2.0 1.0,3.0 20 2.0 1.0,2.0 0.803 
PAR at T4 23 3.0 2.0,6.0 19 3.0 2.0,4.0 19 3.0 2.0,4.0 0.628 
PAR Improvement 23 26.0 21.0,38.0 19 27.0 20.0,35.0 19 29.0 24.0,31.0 0.897 
PAR Improvement % 23 88.9 80.9,94.4 19 90.0 87.5,92.0 19 91.2 85.0,93.5 0.749 
 
PAR, peer assessment rating 
* from Kruskal-Wallis test 
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Supplementary Table 6. Results of crude and adjusted regression models for primary and secondary outcomes 
(Intention-to-Treat analysis) 
 
   
Crude model: only group and 
center effects 
 
Adjusted modeling: group, center, 
and confounding 
   b 95% CI P  b 95% CI P 
Monthly space closure rate 
T1-T2 
Group 
(Ref=Fixed-only) 
Accel -0.09 -0.42,0.23 0.569   -0.10 -0.40,0.21 0.529 
  Sham 0.01 -0.33,0.35 0.964   -0.00 -0.31,0.31 0.994 
 Gender   NT       0.33 0.08,0.59 0.011 
 Malocclusion   NT       0.08 -0.07,0.24 0.304 
 Extraction   NT       0.26 0.05,0.48 0.016 
 PAR T1   NT       -0.00 -0.01,0.01 0.988 
 Spaces T3   NT       0.07 0.01,0.12 0.013 
               
Monthly space closure rate 
T1-T3 
Group 
(Ref=Fixed-only) 
Accel 0.07 -0.19,0.33 0.607   0.13 -0.12,0.38 0.317 
  Sham -0.13 -0.40,0.14 0.351   -0.10 -0.36,0.16 0.450 
 Gender   NT       0.19 -0.03,0.40 0.087 
 Malocclusion   NT       0.12 -0.01,0.25 0.082 
 Extraction   NT       0.13 -0.05,0.30 0.157 
 PAR T1   NT       0.01 -0.00,0.02 0.075 
 Spaces T3   NT       0.06 0.01,0.10 0.012 
                  
Treatment duration in 
months 
Group 
(Ref=Fixed-only) 
Accel 3.09 0.16,6.02 0.039   2.57 -0.26,5.40 0.076 
  Sham 0.52 -2.62,3.66 0.747   0.61 -2.42,3.64 0.694 
 Gender   NT       -1.11 -3.46,1.24 0.355 
 PAR T1   NT       0.11 -0.01,0.22 0.063 
                  
Number of visits 
Group 
(Ref=Fixed-only) 
Accel 1.34 -0.42,3.09 0.136   1.03 -0.69,2.75 0.240 
  Sham -0.27 -2.15,1.62 0.782   -0.16 -2.00,1.68 0.864 
 Gender   NT       0.07 -1.36,1.50 0.923 
 PAR T1   NT       0.06 -0.01,0.12 0.099 
                  
Number of breakages 
Group 
(Ref=Fixed-only) 
Accel 0.10 -1.00,1.20 0.858   0.15 -1.00,1.29 0.801 
  Sham -0.17 -1.35,1.01 0.783   -0.19 -1.41,1.03 0.761 
 Gender   NT       -0.20 -1.15,0.76 0.688 
 PAR T1   NT       -0.00 -0.05,0.04 0.913 
                  
Change in PAR 
Group 
(Ref=Fixed-only) 
Accel -0.88 -7.25,5.49 0.786   -0.31 -1.47,0.85 0.601 
  Sham -2.37 -9.04,4.30 0.486   0.54 -0.70,1.78 0.395 
 Gender   NT       -0.45 -1.41,0.51 0.360 
 PAR T1   NT       0.97 0.92,1.01 <0.001 
                  
% change in PAR 
Group 
(Ref=Fixed-only) 
Accel -1.61 -5.51,2.29 0.420   -1.23 -4.57,2.12 0.472 
  Sham 1.50 -2.62,5.62 0.475   2.27 -1.31,5.84 0.214 
 Gender   NT       -1.85 -4.63,0.93 0.192 
 PAR T1   NT       0.28 0.14,0.41 <0.001 
 
b, unstandardized coefficient; CI, confidence interval; NT, not tested; PAR, peer assessment rating. 
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Supplementary Table 7. Explorative assessment of mean time intervals between appointments (Intention-to-Treat 
analysis) 
 
 Group 1  Group 2  Group 3  
 n median IQR  n median IQR  n median IQR P* 
Time interval in days 24 50.7 47.8,55.4   19 52.3 46.0,57.4   20 48.3 44.7,55.1 0.279 
 
IQR, interquartile range 
* from Kruskal-Wallis test 
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Supplementary Table 8. Explorative assessment for interaction effects on the primary/secondary outcomes of 
severe irregularity at baseline, severe spaces at T1, and severe PAR at baseline. Significant p values indicate 
that the effect of randomized intervention on the listed outcome differs between patients with severe and non-
severe conditions (Intention-to-Treat analysis). 
 
 P value for interaction 
 Severe irregularity 
(>7mm) 
Severe spacing 
(>7mm) 
Severe PAR (>30 
points) 
Monthly space closure rate T1-T2 0.484 0.563 0.433 
Treatment duration in months 0.112 0.121 0.969 
% change in PAR 0.852 0.343 0.139 
PAR, peer assessment rating. 
 
 
